News Archive
- 5th Nov 2009 - AIMSPRO receives US orphan-drug designation for ALS
- 29th Sep 2009 - Ceremben Permit Approved
- 22nd Jul 2009 - Patent granted by the OAPI
- 2nd Jun 2009 - Health Director Article: Krabbe’s disease and Orphan Status
- 2nd Jun 2009 - Health Director Article: Harmonisation Helps
- 2nd Jun 2009 - Health Director Article: Anatomy of the Clinical Trial application process
- 19th May 2009 - AIMSPRO designated as an orphan drug
- 14th May 2009 - Ceremben granted an Equine Research Permit
- 5th May 2009 - Thanks to the trustees of Jakafraik Properties Limited
- 3rd Mar 2009 - Daval investigation concluded
- 16th Jan 2009 - Ceremben to be submitted to field trialling.
- 10th Dec 2008 - Recruitment commenced
- 18th Apr 2008 - Clinical Trial Authorisation
- 20th Mar 2008 - Multiple Sclerosis Trial
- 17th Mar 2008 - Decision on Terminated Clinical Trial
- 25th Feb 2008 - Notice to shareholders
- 18th Feb 2008 - Horse Trial Approval
- 16th Jan 2008 - Listing
- 15th Jan 2008 - Launch of Ceremben
- 14th Jan 2008 - Approval for two studies
- 20th Dec 2007 - Accepted for Membership of the Association of the British Pharmaceutical Industry
- 9th Oct 2007 - Trials
- 29th Nov 2006 - 2006 Annual General Meeting
- 25th Nov 2006 - High Court Claim
- 24th Oct 2006 - "Aimspro" in Mexico
- 22nd May 2006 - Internet prescriptions